Publicaciones en colaboración con investigadores/as de University of Pisa (6)

2023

  1. Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies

    Rheumatology (United Kingdom), Vol. 62, Núm. 1, pp. 243-255

  2. ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products

    Clinical and experimental rheumatology, Vol. 41, Núm. 3, pp. 543-553

2021

  1. SARS-CoV-2 infection in patients with primary Sjögren syndrome: Characterization and outcomes of 51 patients

    Rheumatology (United Kingdom), Vol. 60, Núm. 6, pp. 2946-2957

2020

  1. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

    The Lancet Rheumatology, Vol. 2, Núm. 2, pp. e71-e83

2011

  1. Preliminary criteria for the very early diagnosis of systemic sclerosis: Results of a Delphi consensus study from EULAR scleroderma trials and research group

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 3, pp. 476-481

2010

  1. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database

    Journal of Rheumatology, Vol. 37, Núm. 7, pp. 1488-1501